上调的DDX39在上皮上腺癌中与患者的生存率有关
Yoshiatsu Tanaka1, Shin-Nosuke Yamashita1, Shajedul Islam1
1Advanced Research Promotion Centre, Health Sciences University of Hokkaido, Ishikari-Tobetsu, Japan.
Anticancer research
|January 31, 2025
概括
高DDX39表达表明上腺皮癌的预后不佳. 这种RNA螺旋酶可能作为这种罕见而具有攻击性的上皮层癌症的新奇预后生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 上皮层癌 (ACC) 是一种罕见的上皮层癌症,存活率很低.
- 目前的治疗方法提供了有限的改善,早期检测仍然具有挑战性.
- 了解ACC生物学和识别预后生物标志物至关重要.
研究的目的:
- 研究DDX39在上皮癌中的临床病理作用.
- 为了确定DDX39表达是否与患者的存活相关.
主要方法:
- 对DDX39mRNA表达和生存数据的分析.
- 使用的生物信息平台:GEPIA,GEPIA2和UALCAN.
主要成果:
- 在ACC组织中,DDX39被显著上调.
- 增加DDX39表达与患者的存活率相反相关.
结论:
- DDX39可以作为上腺皮癌的潜在预后生物标志物.
- 进一步研究DDX39在ACC中的作用是有必要的.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321


